Psi Advisors, LLC Nymox Pharmaceutical Corp Transaction History

Psi Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 19, 2023	BUY	$0.28 - $0.74 $56 - $148	200 Added 20.0%	1,200 $0
Q2 2022 Jul 18, 2022	BUY	$0.38 - $1.41 $380 - $1,410	1,000 New	1,000 $0
Q1 2022 Apr 20, 2022	SELL	$1.21 - $2.0 $9,680 - $16,000	-8,000 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$0.95 - $2.1 $4,750 - $10,500	5,000 Added 166.67%	8,000 $10,000
Q3 2021 Nov 12, 2021	BUY	$1.3 - $2.23 $3,900 - $6,690	3,000 New	3,000 $6,000

150K

Ticker NYMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,265,000
Market Cap $42.9M
Description
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperpl...

Get notified when there are updates to the investment portfolio of Psi Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Psi Advisors, LLC with notifications on news.